-

AHF Urges WHO: Save Critical HIV Tech

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) urges the World Health Organization (WHO) to call on manufacturers of vital point-of-care (POC) CD4 equipment, including Abbott Laboratories and Becton Dickinson (BD), to continue production of the HIV testing equipment and any necessary commodities that ensure proper functioning.

“Working in 46 countries, AHF country teams are seeing the consequences of Abbott’s and BD’s decisions firsthand, particularly in Africa and Asia. POC CD4 machines are scarce, if countries have them at all, along with the needed reagent cartridges that allow for 20-minute results. The companies have also stopped making service calls on existing equipment, abandoning patients and leaving healthcare workers empty-handed,” said AHF Senior Global Medical Director Dr. Adele Schwartz Benzaken. “We urge the WHO to speak up and call on makers of CD4 testing equipment to begin producing the machines and reagents immediately, along with providing support to existing equipment in the field, as many are failing globally.”

A previous, yet now reversed, shift in preference by WHO from CD4 to viral load testing to assess the health of HIV-positive patients caused manufacturers of CD4 machines to announce a dangerous wind down in production, of which AHF warned about.

CD4 testing shows how HIV damages our immune system since the virus targets and destroys CD4 cells. While CD4 count is not vital for HIV diagnosis, it’s extremely important upon diagnosis, as the patient’s condition may have already progressed to AIDS—thus essential to the HIV continuum of care.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 46 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

AIDS Healthcare Foundation


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

More News From AIDS Healthcare Foundation

Gilead's Earnings Skyrocket as Florida’s AIDS Drug Program Falters, says AHF

LOS ANGELES--(BUSINESS WIRE)--Gilead's Earnings per Share Expected to Be Up 52% as Florida’s and other States’ AIDS Drug Programs Falters, says AHF...

AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities

LOS ANGELES--(BUSINESS WIRE)--AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities...

AHF Webinar Spotlights Equity as Pandemic Agreement Nears Finish Line

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Will Equity Prevail? The PABS Annex Negotiations at Their Final Hour,” on Thursday, April 23, 2026 at 10:00 AM EDT, virtually via Zoom. Register here. As WHO Pandemic Agreement negotiations enter a decisive phase ahead of the next Intergovernmental Working Group (IGWG) session, Member States are working to finalize the Pathogen Access and Bene...
Back to Newsroom